George Church launches stem cell programming start-up GC Therapeutics has Church’s initials, a 4-day cell differentiation platform, and $65 million ...

Wednesday, Ginkgo Bioworks Holdings Inc (NYSE: DNA) released preliminary FY23 sales of $250 million-$260 million, compared to the consensus of $258.65 million. Preliminary cell engineering and ...